Immunosuppressive agents that inhibit calcineurin function and uses of these agents
US6686450B1 · kind B1 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 1999 |
| Grant date | Feb 3, 2004 |
| Priority date | — |
| Expiry date | Jun 17, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel immunosuppressive agents. In particular, the invention provides immunosuppressive agents that bind calcineurin and/or that inhibit interaction between calcineurin and NF-AT. The invention also provides analogs of these agents, nucleic acids encoding the agents and/or their analogs, gene therapy vectors, etc., and methods of making and using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.